Tessera
Folgen

Luis Ostrosky, MD, FIDSA

@drluiso.bsky.social

ID specialist and medical mycologist. Transplant ID. Healthcare epidemiology. Healthcare Quality. All views are my own.

173 Posts1765 Follower2021 Folgt
Luis Ostrosky, MD, FIDSA@drluiso.bsky.social · 4mo ago

Major news in the #Candida world! C. glabarata is now the most common cause of candidemia in US hospitals. Collaboration between CDC, UTHealth and Harvard investigators #IDSky #MedSky @msgerc.bsky.social

Ilan Schwartz@germhuntermd.bsky.social · 4mo ago

Candida glabrata emerges as the most common cause of candidemia: analysis of a large hospital-based database, United States, 2016–2024 academic.oup.com/cid/advance-... Jeremy Gold & colleagues at CDC Mycotic Diseases Branch, @jessicalittlemd.bsky.social and @drluiso.bsky.social

Line graph showing the percentage distribution of Candida species from 2016 to 2024. Candida albicans is the most common species in most years, declining from about 36% to 32%. Candida glabrata increases overall, rising from about 25% in 2016 to a peak around 34% in 2024. Candida parapsilosis fluctuates between roughly 8% and 17% before declining to about 8% by 2024. Candida tropicalis and unspecified/other species remain relatively stable at lower levels (about 6–12%). Multiple-species infections decrease slightly over time. Candida auris is absent before 2022 and then increases to about 5% by 2023–2024.
Luis Ostrosky, MD, FIDSA@drluiso.bsky.social · 5mo ago

Great data on pre-transplant serologic testing for fungal infections in the US by my friends at the CDC and @jessicalittlemd.bsky.social #IDSky #MedSky academic.oup.com/mmy/advance-...

Pretransplant serologic testing for fungal infections in a large commercial health insurance database, United States

Abstract. Reactivation of latent fungal infections poses a substantial risk for solid organ transplantation (SOT) and hematopoietic cell transplantation (H

academic.oup.com

IDSA@idsainfo.bsky.social · 6mo ago

Tomorrow! Join us for for a webinar on practical, evidence-based approaches to fungal diagnostic testing. Presented by Julie M. Steinbrink, MD, MHS, of Duke University and Martin Hönigl, MD, of Medical University of Graz, Austria. Register: https://bit.ly/3OiX1Ez

Bild
Luis Ostrosky, MD, FIDSA@drluiso.bsky.social · 6mo ago

Framework for pivoting to #DOOR in #mycology! Very excited about this publication from @msgerc.bsky.social #IDSky #MedSky academic.oup.com/ofid/article...

Development Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases

Utilizing a modified Delphi process, 53 fungal experts from 16 countries developed consensus endpoints for clinical trials targeting invasive candidiasis,

academic.oup.com